Evaluation of the prognostic value of fibrinolytic elements in invasive breast carcinoma patients

Rok, strany: 2020, 1146 - 1156

Breast cancer (BrC) is one of the most serious oncological problems in the world. The aim of the study was to evaluate concentrations of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) and their ratios: t-PA/PAI-1 and PAI-1/t-PA in breast cancer patients and in healthy individuals and to estimate the ability of fibrinolytic parameters in predicting neoplasm disease and disease relapse. One hundred and five women were enrolled in the study, including 60 cases with primary BrC, (M0) and 45 healthy females. Follow-up was completed in all BrC patients with a 16.7% recurrence rate. An immunoassay of t-PA, PAI-1 in all cases was made as well as the immunohistochemistry of estrogen and progesterone receptors, human epidermal growth factor receptor 2, E-cadherin, and Ki-67 was performed in BrC subjects. A significantly higher PAI-1 concentration in breast cancer patients below the age of 55 than in controls was obtained. According to the ROC curve analysis, the PAI-1 concentration demonstrates the most accurate prognostic value with the cut-off point at 33.91 ng/ml, with 90% sensitivity and 36% specificity, which discriminates between controls and cancer patients. However, t-PA presents the highest area under the receiver-operating characteristic curves (AUCROC)=0.634 in predicting disease relapse with the cut-off value of 5.3 ng/ml. According to the Kaplan-Meier curves, a high concentration of t-PA (>5 ng/ml) and a lower PAI-1/t-PA ratio (<7.5) are associated with shorter survival. Evaluation of plasma t-PA and PAI-1 concentrations may deliver relevant prognostic information for breast cancer patients.

ISO 690:

Ruszkowska-Ciastek, B., Kwiatkowska, K., Bielawska, S., Robakowska, M., Bielawski, K., Rhone, P. 2020. Evaluation of the prognostic value of fibrinolytic elements in invasive breast carcinoma patients. In NEOPLASMA, vol. 67, no.5, pp. 1146-1156. 0028-2685. DOI: https://doi.org/10.4149/neo_2020_191022N1076

APA:

Ruszkowska-Ciastek, B., Kwiatkowska, K., Bielawska, S., Robakowska, M., Bielawski, K., Rhone, P. (2020). Evaluation of the prognostic value of fibrinolytic elements in invasive breast carcinoma patients. NEOPLASMA, 67(5), 1146-1156. 0028-2685. DOI: https://doi.org/10.4149/neo_2020_191022N1076

Vydavateľ: AEPress, Ltd.